Aalok Malankar
Family Medicine · Windsor Mill, MDNPI 1124265087
Payments from drug & device makers
Across 452 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$1K
- GSK$619
- AbbVie$575
- Pfizer$505
- Lilly USA, LLC$403
- plus $3K from 21 others
What the payments were for
- Speaking & faculty fees$601%
- Food & beverage$7,36199%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 78 | $1,348 |
| AstraZeneca | 62 | $1,068 |
| GSK | 36 | $619 |
| AbbVie(2 entities) | 39 | $575 |
| Pfizer | 39 | $505 |
| Lilly USA, LLC | 31 | $403 |
| Sanofi-aventis U.S. LLC | 25 | $400 |
| Boehringer Ingelheim | 20 | $376 |
| Novartis | 22 | $375 |
| Bayer | 12 | $221 |
| Amarin Pharma, Inc. | 14 | $198 |
| Teva Pharmaceuticals USA, Inc. | 11 | $184 |
| Amgen | 11 | $182 |
| Esperion Therapeutics, Inc. | 6 | $176 |
| Astellas Pharma US Inc | 7 | $132 |
| Abbott | 6 | $123 |
| Kowa Pharmaceuticals America, Inc. | 6 | $86 |
| Merck | 6 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $84 |
| Mylan Specialty L.p. | 3 | $62 |
| Sanofi | 1 | $60 |
| Biogen | 2 | $46 |
| Sunovion Pharmaceuticals Inc. | 3 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Philips North America LLC | 2 | $31 |
| Johnson & Johnson | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,449 in reported general payments places this provider in the 90th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $54,097 |
| JardianceEmpagliflozin | 30 | $46,209 |
| EliquisApixaban | 31 | $20,376 |
| JanuviaSitagliptin Phosphate | 14 | $19,275 |
| FarxigaDapagliflozin Propanediol | 16 | $15,433 |
| TrulicityDulaglutide | 14 | $15,309 |
| EntrestoSacubitril/Valsartan | 18 | $14,911 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $5,418 |
| Hydromorphone ErHydromorphone Hcl | 12 | $3,819 |
| Atorvastatin Calcium | 159 | $1,351 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $989 |
| Amlodipine Besylate | 150 | $959 |
| Oxycodone Hcl | 30 | $913 |
| Metoprolol Succinate | 59 | $792 |
| Pravastatin Sodium | 20 | $700 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,348 | $54,09754 claims |
| Boehringer IngelheimJardiance | $376 | $46,20930 claims |
| PfizerEliquis | $505 | $20,37631 claims |
| MerckJanuvia | $84 | $19,27514 claims |
| AstraZenecaFarxiga | $1,068 | $15,43316 claims |
| Lilly USA, LLCTrulicity | $403 | $15,30914 claims |
| NovartisEntresto | $375 | $14,91118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,193 family medicine providers in Maryland.
Other family medicine in Windsor Mill
- Stephen OngOxon Hill$5.9M
- Stephan BartWoodstock$1.7M
- Karen DonaldsonBaltimore$899K
- Rajiv DuaColumbia$765K
- Greg TampusLutherville Timonium$735K
- Louis JacquesBaltimore$522K
- Stephanie MellerOxon Hill$518K
- Sharon ChungGlen Burnie$333K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.